Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06184815
Other study ID # IMSST1D
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date January 1, 2024
Est. completion date November 30, 2024

Study information

Verified date December 2023
Source Instituto Mexicano del Seguro Social
Contact David Sanchez, MD
Phone 8183714100
Email davidsanchez70@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This trial compared an structured education programme and multidisciplinary treatment vs an standard treatment in type 1 diabetes patient, the Primary outcome is glycemic control at 6-month follow up and secondary outcome are cardiovascular risk factors control, diabetes related distress, anxiety and depressive symptoms, hypoglycemia awareness.


Description:

Both groups will received individualized treatment in the clinic, the intervention group will consist of 12 educational sessions during 4 months, and multidisciplinary treatment each month given by endocrinology, nutrition and psychology during 4 months, the control group will received education in outpatient clinic of endocrinology and will be sent as referral to specialties of nutrition and psychology as standard follow-up of the clinic.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 120
Est. completion date November 30, 2024
Est. primary completion date November 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 15 Years to 75 Years
Eligibility Inclusion Criteria: - Type 1 diabetes - Diabetes duration >1 year - BMI 18.5-40kg/m2 - A1c 6.5-13% Exclusion Criteria: - Pregnancy - Dementia or severe cognitive impairment - Uncontrolled psychiatric disorder - Absence of >20% of the educational sessions

Study Design


Intervention

Behavioral:
Educational programme 12
Consists of 12 lessons, diabetes education slides and patient materials, with a duration of 4 months and multidisciplinary treatment
Standard education and treatment
Outpatient management and education in the office and consultation referral to nutrition and psychology

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Instituto Mexicano del Seguro Social

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in Glycemic Control Measured by A1c Difference between baseline A1c and A1c at 6 month follow up Baseline and 6 months
Secondary Changes in Lipid Control Measured by LDLc, HDLc, non-HDLc, Triglycerides, Total Cholesterol Difference between basal lipid profile and lipid profile at 6 month follow up Baseline and 6 months
Secondary Changes in insulin resistance control Measured by eGDR Difference between basal eGDR and eGDR at 6 month follow up Baseline and 6 months
Secondary Changes in Mental health Measured by DDS, GAD7 and PHQ9 Difference between basal DDS, GAD7 and PHQ9 and DDS, GAD7 and PHQ9 at 6 month follow up Baseline and 6 months
Secondary Changes Anthropometry Measured by BMI and WC Difference between basal BMI and WC and BMI and WC at 6 months Baseline and 6 months
Secondary Changes in Glycemic Control Measured by severe hypoglycemia Difference between severe hypoglycemia in the las 6 months and severe hypoglycemia at 6 months of follow up Baseline and 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05653518 - Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes N/A
Enrolling by invitation NCT05515939 - Evaluating the InPen in Pediatric Type 1 Diabetes
Completed NCT05109520 - Evaluation of Glycemic Control and Quality of Life in Adults With Type 1 Diabetes During Continuous Glucose Monitoring When Switching to Insulin Glargine 300 U/mL
Recruiting NCT04016987 - Automated Structured Education Based on an App and AI in Chinese Patients With Type 1 Diabetes N/A
Active, not recruiting NCT04190368 - Team Clinic: Virtual Expansion of an Innovative Multi-Disciplinary Care Model for Adolescents and Young Adults With Type 1 Diabetes N/A
Recruiting NCT05413005 - Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Type 1 Diabetes Mellitus Early Phase 1
Active, not recruiting NCT04668612 - Dual-wave Boluses in Children With Type 1 Diabetes Insulin Boluses in Children With Type 1 Diabetes N/A
Completed NCT02837094 - Enhanced Epidermal Antigen Specific Immunotherapy Trial -1 Phase 1
Recruiting NCT05414409 - The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action Phase 2
Recruiting NCT05670366 - The Integration of Physical Activity Into the Clinical Decision Process of People With Type 1 Diabetes N/A
Active, not recruiting NCT05418699 - Real-life Data From Diabetic Patients on Closed-loop Pumps
Completed NCT04084171 - Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6 N/A
Recruiting NCT06144554 - Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
Recruiting NCT05379686 - Low-Dose Glucagon and Advanced Hybrid Closed-Loop System for Prevention of Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes N/A
Recruiting NCT05153070 - Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes Phase 2
Completed NCT05281614 - Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D Early Phase 1
Withdrawn NCT04259775 - Guided User-initiated Insulin Dose Enhancements (GUIDE) to Improve Outcomes for Youth With Type 1 Diabetes N/A
Active, not recruiting NCT01600924 - Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in Diabetes
Completed NCT02750527 - Pediatric Population Screening for Type 1 Diabetes and Familial Hypercholesterolemia in Lower Saxony, Germany
Completed NCT02914886 - Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS) Phase 4